Global Vascular Patches Market Size study & Forecast, by Material (Biologic Vascular Patches, Synthetic Vascular Patches), by Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease,

Global Vascular Patches Market Size study & Forecast, by Material (Biologic Vascular Patches, Synthetic Vascular Patches), by Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysm, Vascular Bypass Surgery, Congenital Heart Disease, Other Applications), by End User (Hospitals, Ambulatory Surgical Centers) and Regional Analysis, 2023-2030

Global Vascular Patches Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Vascular patches are medical equipment used in vascular surgery to repair or reinforce blood vessels. These patches are typically made from biocompatible materials and are designed to provide support to weakened or damaged blood vessels, helping to restore normal blood flow and prevent complications such as aneurysms or leaks. The key factors driving the market growth are the rising prevalence of vascular diseases, growing demand for minimally invasive procedures, increasing number of cardiovascular surgeries, and growing geriatric population that anticipated to support the market growth during forecast period 2023-2030.

Moreover, the growing geriatric population is anticipated to support the growth of the Vascular Patches Market. Vascular diseases, such as atherosclerosis and aneurysms, become more common with age. As the geriatric population expands, there is a higher prevalence of these conditions, leading to an increased demand for vascular patches to treat or repair damaged blood vessels. According to the World Bank, 9% of the total population aged 65 and older lived in the world in 2020, and in 2021 the rate reached 10%. As a result, the rising old age population is anticipated to support the market growth. Additionally, the growing number of hospitals & surgical centers, and the rising adoption of biological patches are anticipated to create lucrative opportunities for the market. However, the high procedural cost of vascular surgeries and associated products stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Vascular Patches Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, favorable government reimbursements for vascular surgeries, and a high incidence of vascular diseases. Whereas, the Asia Pacific is expected to grow with the highest CAGR over the forecast period, owing to factors such as the rising prevalence of chronic heart diseases, growing public healthcare spending, and rising geriatric population.

Major market player included in this report are:
LeMaitre Vascular, Inc. (US)
Baxter International, Inc. (US)
W. L. Gore & Associates, Inc. (US)
Getinge AB (Sweden)
B Braun (Germany)
Artivion, Inc (US)
Edwards Lifesciences Corporation (US)
Aziyo Biologics, Inc. (US)
Terumo Corporation (Japan)
Labcor Laboratórios Ltda. (Brazil)

Recent Developments in the Market:
 In December 2021, Aziyo Biologics, Inc. has secured a substantial $14 million investment through public equity (PIPE) financing to fuel and amplify the company's expansion in the field of regenerative medicine.

Global Vascular Patches Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Material, Application, End User, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Material:
Biologic Vascular Patches
Synthetic Vascular Patches

By Application:
Carotid Endarterectomy
Open Repair of Abdominal Aortic Aneurysm
Vascular Bypass Surgery
Congenital Heart Disease
Other Applications

By End User:
Hospitals
Ambulatory Surgical Centers

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
LeMaitre Vascular, Inc. (US)
Baxter International, Inc. (US)
W. L. Gore & Associates, Inc. (US)
Getinge AB (Sweden)
B Braun (Germany)
Artivion, Inc (US)
Edwards Lifesciences Corporation (US)
Aziyo Biologics, Inc. (US)
Terumo Corporation (Japan)
Labcor Laboratórios Ltda. (Brazil)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.